These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25973451)

  • 1. Clinical Inquiry: What therapies alleviate symptoms of polycystic ovary syndrome?
    Moreno LE; Bonnell A; Neher JO; Safranek S
    J Fam Pract; 2015 Apr; 64(4):247-9. PubMed ID: 25973451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.
    Buzney E; Sheu J; Buzney C; Reynolds RV
    J Am Acad Dermatol; 2014 Nov; 71(5):859.e1-859.e15; quiz 873-4. PubMed ID: 25437978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
    Svendsen PF; Nilas L; Nørgaard K; Madsbad S
    Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness and safety of treatments used for polycystic ovarian syndrome management in adolescents: a systematic review and network meta-analysis protocol.
    Al Khalifah RA; Flórez ID; Dennis B; Neupane B; Thabane L; Bassilious E
    Syst Rev; 2015 Sep; 4():125. PubMed ID: 26420636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metformin treatment with or without life style changes in patients with polycystic ovary syndrome].
    Petrányi G; Zaoura-Petrányi M
    Orv Hetil; 2011 Apr; 152(16):628-32. PubMed ID: 21454179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin and oral antidiabetic agents for treatment of polycystic ovary syndrome.
    Kuscu NK; Koyuncu FM
    Medscape Womens Health; 2002; 7(5):3. PubMed ID: 12466732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
    Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials.
    Almalki HH; Alshibani TM; Alhifany AA; Almohammed OA
    BMC Womens Health; 2020 Apr; 20(1):68. PubMed ID: 32248801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazolidinediones for treatment of polycystic ovary syndrome.
    Stout DL; Fugate SE
    Pharmacotherapy; 2005 Feb; 25(2):244-52. PubMed ID: 15767238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin versus lifestyle changes in treating women with polycystic ovary syndrome.
    Curi DD; Fonseca AM; Marcondes JA; Almeida JA; Bagnoli VR; Soares JM; Baracat EC
    Gynecol Endocrinol; 2012 Mar; 28(3):182-5. PubMed ID: 22309675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug treatments for polycystic ovary syndrome.
    Radosh L
    Am Fam Physician; 2009 Apr; 79(8):671-6. PubMed ID: 19405411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic ovary syndrome (PCOS) in the adolescent patient: recommendations for practice.
    Snyder BS
    Pediatr Nurs; 2005; 31(5):416-21. PubMed ID: 16295159
    [No Abstract]   [Full Text] [Related]  

  • 13. Polycystic ovary syndrome.
    Ehrmann DA
    N Engl J Med; 2005 Mar; 352(12):1223-36. PubMed ID: 15788499
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of polycystic ovary syndrome.
    Ajossa S; Guerriero S; Paoletti AM; Orrù M; Melis GB
    Minerva Ginecol; 2004 Feb; 56(1):15-26. PubMed ID: 14973407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovarian syndrome.
    Yawn V
    Adv NPs PAs; 2012 Dec; 3(12):11-4; quiz 15. PubMed ID: 23270212
    [No Abstract]   [Full Text] [Related]  

  • 16. Trends, in Diagnosis and Treatment of Polycystic Ovarian Syndrome by Specialty.
    Uliassi N; Sullivan S; Damle L; Gomez-Lobo V
    J Reprod Med; 2016 Sep; 61(9-10):441-446. PubMed ID: 30383942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin and troglitazone in the treatment of female infertility associated with polycystic ovarian syndrome.
    Sangraula H; Paudel KR; Sharma M
    JNMA J Nepal Med Assoc; 2009; 48(176):335-9. PubMed ID: 21105563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial.
    Fux Otta C; Wior M; Iraci GS; Kaplan R; Torres D; Gaido MI; Wyse EP
    Gynecol Endocrinol; 2010 Mar; 26(3):173-8. PubMed ID: 20148739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovarian syndrome-current pharmacotherapy and clinical implications.
    Rashid R; Mir SA; Kareem O; Ali T; Ara R; Malik A; Amin F; Bader GN
    Taiwan J Obstet Gynecol; 2022 Jan; 61(1):40-50. PubMed ID: 35181044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update.
    Katsiki N; Hatzitolios AI
    Curr Opin Obstet Gynecol; 2010 Dec; 22(6):466-76. PubMed ID: 20724929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.